ArticleFrontiers in oncology2023

Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia.

Michele Malagola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.